UPDATE 3-Valeant to sell assets for $2.12 bln to ease debt load
Jan 10 (Reuters) - Valeant Pharmaceuticals International is selling its Dendreon cancer treatment business and three skincare brands for $2.12 billion as the troubled Canadian drugmaker looks to... [Source]
Publication Date:Origin: reuters.com
Category: hotStocksNews
Topics: looks, Canadian drugmaker, troubled, billion, brands, skincare, and three, business, treatment, cancer, Dendreon, selling, International, Pharmaceuticals, Valeant, (Reuters), assets, 3-Valeant, UPDATE
